These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35253778)

  • 1. PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy.
    Nguyen TT; Kim YJ; Lai TT; Nguyen PT; Koh YH; Nguyen LTN; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(4):1201-1217. PubMed ID: 35253778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.
    Creed RB; Goldberg MS
    Neuroscience; 2020 Jun; 437():64-75. PubMed ID: 32353461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
    Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
    Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
    Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P
    J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
    Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
    Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
    Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
    J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits.
    Gezer AO; Kochmanski J; VanOeveren SE; Cole-Strauss A; Kemp CJ; Patterson JR; Miller KM; Kuhn NC; Herman DE; McIntire A; Lipton JW; Luk KC; Fleming SM; Sortwell CE; Bernstein AI
    Neurobiol Dis; 2020 Jul; 141():104947. PubMed ID: 32422283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous loss of Engrailed-1 and α-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.
    Stetzik L; Mercado G; Steiner JA; Lindquist A; Gilliland C; Schulz E; Meyerdirk L; Smith L; Molina J; Moore DJ
    Neurobiol Dis; 2024 Oct; 200():106647. PubMed ID: 39187209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
    Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
    Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.
    Han R; Wang Q; Xiong X; Chen X; Tu Z; Li B; Zhang F; Chen C; Pan M; Xu T; Chen L; Wang Z; Liu Y; He D; Guo X; He F; Wu P; Yin P; Liu Y; Yan X; Li S; Li XJ; Yang W
    J Clin Invest; 2024 Oct; 134(20):. PubMed ID: 39403921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
    Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
    Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
    Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation.
    Kweon SH; Ryu HG; Kwon SH; Park H; Lee S; Kim NS; Ma SX; Jee HJ; Kim S; Ko HS
    Brain; 2024 Dec; 147(12):4072-4083. PubMed ID: 38976650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
    Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice.
    Boyd SL; Kuhn NC; Patterson JR; Stoll AC; Zimmerman SA; Kolanowski MR; Neubecker JJ; Luk KC; Ramsson ES; Sortwell CE; Bernstein AI
    Toxicol Sci; 2023 Oct; 196(1):99-111. PubMed ID: 37607008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reelin protects against pathological α-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease.
    Cho E; Kim K; Kim H; Cho SR
    Neurobiol Dis; 2022 Dec; 175():105898. PubMed ID: 36270619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy.
    Parmasad JA; Ricke KM; Nguyen B; Stykel MG; Buchner-Duby B; Bruce A; Geertsma HM; Lian E; Lengacher NA; Callaghan SM; Joselin A; Tomlinson JJ; Schlossmacher MG; Stanford WL; Ma J; Brundin P; Ryan SD; Rousseaux MWC
    Cell Death Dis; 2024 Apr; 15(4):246. PubMed ID: 38575601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.